NCT04077125View on ClinicalTrials.gov

Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

March 1, 2019

Conditions

Minimal Hepatic Encephalopathy

Interventions

DRUG

Rifaximin

to investigate changes in cerebral, splanchnic hemodynamics and endothelial function in cirrhotic patients with MHE after 15 days of rifaximin therapy (1200 mg/d)

Trial Locations (1)

00168

Fondazione Policlinico Agostino Gemelli IRCCS, Roma

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04077125 - Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter